glp 1 agonists diabetes GLP-1 receptor for individualized treatment of type 2 mellitus Schematic illustration of monoagonists, dual

Y.) 8 , e12268 (2022)

The surge in popularity of medications that mimic its effects has sparked widespread curiosity

I n the future, innovation will likely focus on five key areas: long-acting formulations, oral delivery methods, multi-target approaches, combination therapies, and expanding the range of indications

They argued that the whole point of insurance is to have benefits available when people need them

Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice

doi: 10.2337/dc12-2469